TLDR Nanostructured lipid carriers improve minoxidil delivery for hair loss treatment.
This document describes the development of a nanostructured lipid carrier (NLC) for the topical delivery of minoxidil (MXD) to treat hair loss. The NLCs were composed of stearic acid, oleic acid, and surfactants, and showed better stability and retention in the skin than solid lipid nanoparticles (SLNs). The study suggests that NLCs are a promising drug delivery system for MXD and could improve patient acceptance and tolerability for the topical delivery of MXD.
95 citations,
July 2015 in “European journal of pharmaceutics and biopharmaceutics” Lipid nanoparticles can help deliver drugs through hair follicles but struggle to penetrate deeper skin layers.
25 citations,
July 2013 in “Journal of Dermatological Science” Six new hair loss factors in men not linked to female hair loss.
229 citations,
August 2002 in “Experimental Gerontology” AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.
77 citations,
March 2001 in “Clinics in Dermatology” Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.
27 citations,
October 1999 in “Experimental and Molecular Pathology” Stump-tailed macaque best for researching hair loss causes and treatments.
38 citations,
November 2016 in “Aaps Pharmscitech” Nanoparticles with more oleic acid improved the delivery and stability of the drug spironolactone.
32 citations,
April 2016 in “Aaps Pharmscitech” Nanostructured lipid carriers improve minoxidil delivery for hair loss treatment.
